Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species
Following their discovery over 50 years ago, mesenchymal stromal cells (MSCs) have become one of the most studied cellular therapeutic products by both academia and industry due to their regenerative potential and immunomodulatory properties. The promise of MSCs as a therapeutic modality has been de...
Main Authors: | Adrienne Wright, Marne L. Arthaud-Day, Mark L. Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.632717/full |
Similar Items
-
Mesenchymal Stromal Cells
by: Stanisław Szala, et al.
Published: (2014-11-01) -
Control of recombinant protein productivity and quality in mammalian cell culture
by: Rendall, Mark Harcus
Published: (2000) -
The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
by: David García-Bernal, et al.
Published: (2021-03-01) -
Mesenchymal stromal precursors are mobilized from the bone marrow during inflammation
by: Jasper eKoning, et al.
Published: (2013-03-01) -
Molecular Interaction Characterization Strategies for the Development of New Biotherapeutic Antibody Modalities
by: Xiangdan Wang, et al.
Published: (2020-03-01)